HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary Morrogh Selected Research

4- (2- hydroxy- 3- tert- butylaminopropoxy)- 2- methylindole (21-009)

7/2012Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary Morrogh Research Topics

Disease

6Neoplasms (Cancer)
04/2015 - 12/2007
5Breast Neoplasms (Breast Cancer)
11/2015 - 03/2010
1Breast Carcinoma In Situ
04/2015
1Lobular Carcinoma
04/2015
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2012

Drug/Important Bio-Agent (IBA)

2ParaffinIBA
07/2012 - 07/2010
2Formaldehyde (Formol)FDA Link
07/2012 - 07/2010
1Transforming Growth Factor beta (TGF-beta)IBA
04/2015
1Indicators and Reagents (Reagents)IBA
04/2015
1DNA (Deoxyribonucleic Acid)IBA
07/2012
14- (2- hydroxy- 3- tert- butylaminopropoxy)- 2- methylindole (21-009)IBA
07/2012
1Anastrozole (Arimidex)FDA LinkGeneric
07/2012
1Estrogen ReceptorsIBA
07/2012
1Biomarkers (Surrogate Marker)IBA
07/2012
1Complementary DNA (cDNA)IBA
07/2012
1CateninsIBA
04/2012
1Cadherins (E-Cadherin)IBA
04/2012
1Trastuzumab (Herceptin)FDA Link
07/2010
13,4-methylenedioxyethamphetamine (MDEA)IBA
12/2007

Therapy/Procedure

3Therapeutics
07/2010 - 03/2010
1Chemoprevention
11/2015
1Ligation
07/2012